BCRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioCryst Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 8.5 USD 3.79% Market Closed

Market Cap: $2.2B

	BioCryst Pharmaceuticals Inc NASDAQ:BCRX	US
	Enlight Renewable Energy Ltd NASDAQ:ENLT	IL
N	Newpoint Financial Corp OTC:NPFC	US
N	Nomura Holdings Inc XMUN:NSE	JP
	Neurocrine Biosciences Inc NASDAQ:NBIX	US
E	Energy Resources Of Australia Ltd OTC:EGRAF	AU
O	Omni Lite Industries Canada Inc OTC:OLNCF	US
	Old Republic International Corp NYSE:ORI	US
	Mondelez International Inc NASDAQ:MDLZ	US
	Meteoric Resources NL ASX:MEI	AU
	Associated British Foods PLC LSE:ABF	UK
	Antero Resources Corp NYSE:AR	US
S	Sun International Ltd JSE:SUI	ZA

Profitability Summary

BioCryst Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

97% > 98%

Exceptional Operating Margin

36%

Negative 3Y Average Operating Margin

-5%

Operating Margin is Increasing

-44% > 36%

Negative Net Margin

-52%

Negative 3Y Average Net Margin

-34%

Net Margin is Increasing

-78% > -52%

Exceptional Free Cash Flow Margin

35%

Negative 3Y Average Free Cash Flow Margin

-9%

Free Cash Flow Margin is Increasing

-46% > 35%

Exceptional ROE

91%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-3%

ROIC is Increasing

-147% > 163%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.